Tissue Regenix Group Share Price | |
---|---|
Price | 61.50 |
Bid | 61.00 |
Ask | 62.00 |
Change | -0.50 (-0.81%) |
Volume | 59,347 |
Open | 61.50 |
High | 61.00 |
Low | 61.00 |
Prev. Close | 61.50 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 70.57m |
Market Capitalisation | £43.05m |
Market Size | 2,000 |
52 Week High | 71.50 |
52 Week High Date | 26-Feb-2024 |
52 Week Low | 49.00 |
52 Week Low Date | 03-Jul-2023 |
# Trades | 6 |
---|---|
Vol. Sold | 59,347 |
Sold Value | £36.24k |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | -31.96085 |
Earnings | -1.908585 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
08-May-24 | 16:35:16 | 61.00 | 70 | Sell* | 61.00 | 62.00 | 42.70 | UT Uncrossing Trade |
08-May-24 | 11:09:30 | 61.30 | 2,261 | Sell* | 61.00 | 62.00 | 1,386 | O Ordinary |
08-May-24 | 09:58:51 | 61.12 | 24,274 | Sell* | 61.00 | 62.00 | 14.84k | O Ordinary |
08-May-24 | 09:58:36 | 61.00 | 24,332 | Sell* | 61.00 | 62.00 | 14.84k | O Ordinary |
08-May-24 | 08:56:14 | 61.00 | 4,592 | Sell* | 61.00 | 62.00 | 2,801 | O Ordinary |
08-May-24 | 08:47:25 | 61.00 | 3,818 | Sell* | 61.00 | 62.00 | 2,329 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
15-Sep-23 | 15-Sep-23 | Buy | Brian Phillips held the position of Independent Non-Executive Director at the time of this trade.Brian Phillips | 54.00 | GBX | 6,773 | 160,001 |
05-Apr-23 | 04-Apr-23 | Buy | David Cocke held the position of CFO at the time of this trade.David Cocke | 0.57 | GBX | 500,000 | 7,120,570 |
05-Apr-23 | 04-Apr-23 | Buy | David Cocke held the position of CFO at the time of this trade.David Cocke | 0.56 | GBX | 928,570 | 7,120,570 |
05-Apr-23 | 04-Apr-23 | Buy | Daniel Lee held the position of CEO at the time of this trade.Daniel Lee | 0.56 | GBX | 928,570 | 8,690,770 |
05-Apr-23 | 04-Apr-23 | Buy | Daniel Lee held the position of CEO at the time of this trade.Daniel Lee | 0.57 | GBX | 500,000 | 8,690,770 |
Tissue Regenix Group is a pioneering, international medical technology company, focusing on the development of regenerative products.